Home
>
National Drug Code (NDC)
>
ULORIC
ULORIC - 64764-918-30 - (febuxostat)
Drug Information of ULORIC
| Product NDC: | 64764-918 |
| Proprietary Name: | ULORIC |
| Non Proprietary Name: | febuxostat |
| Active Ingredient(s): | 40 mg/1 & nbsp; febuxostat |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ULORIC
| Product NDC: | 64764-918 |
| Labeler Name: | Takeda Pharmaceuticals America, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021856 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090213 |
Package Information of ULORIC
| Package NDC: | 64764-918-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (64764-918-30) |
NDC Information of ULORIC
| NDC Code | 64764-918-30 |
| Proprietary Name | ULORIC |
| Package Description | 30 TABLET in 1 BOTTLE (64764-918-30) |
| Product NDC | 64764-918 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | febuxostat |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090213 |
| Marketing Category Name | NDA |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | FEBUXOSTAT |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |
